KE-39

Cat.No.: CSC-C6378J

Species: Homo sapiens (Human)

Source: Lymph Node Metastasis

Morphology: epithelial-like

Culture Properties: Adherent cells

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C6378J
Description
Human cell line derived from gastric cancer
Species
Homo sapiens (Human)
Source
Lymph Node Metastasis
Recommended Medium
Culture Properties
Adherent cells
Morphology
epithelial-like
HLA Typing
Class I HLA-A A*11:01,30:01 HLA-B B*35:01,44:02 HLA-C C*04:01,05:01 Class II HLA-DQ DQB1*03:01,05:01 HLA-DR DRB1*01:03,04:01
Disease
Gastric Adenocarcinoma
Storage and Shipping
Ship in dry ice.
Store in liquid nitrogen.
Synonyms
KE39
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The KE-39 cell line is a human cell line that was derived from a gastric cancer sample. As a model system, the KE-39 cells provide researchers with a valuable tool for investigating the biological characteristics and molecular mechanisms underlying gastric cancer.

By having access to the KE-39 cell line, researchers can explore the genetic alterations, signaling pathways, and other factors that contribute to the development and progression of gastric cancer. This includes investigating the potential roles of oncogenes, tumor suppressor genes, and other molecular drivers in the transformation and proliferation of gastric cancer cells. Furthermore, the KE-39 model has been utilized in preclinical drug screening and evaluation of novel therapeutic strategies targeting gastric cancer. The availability of this cell line has enabled researchers to assess the efficacy and mechanism of action of candidate compounds, which can inform the development of more effective treatment options for patients diagnosed with this type of cancer.

Identifying Upstream and Downstream Genes in KRAS-Amp Cancer Cell Lines

Gastroesophageal adenocarcinomas (GEAs) harbor recurrent amplification of KRAS, leading to marked overexpression of WT KRAS protein. SHP2 phosphatase, which acts to promote KRAS and downstream MAPK pathway activation, is a target in these tumors when combined with MEK inhibition. A custom, focused, secondary screening, CRISPR/Cas9 sgRNA library, was designed. In addition to those targeting genes of interest (Fig. 1A), 3 KRAS-amp cancer cell lines were screened, including 2 cancer cell lines (KE-39 and YCC-1) and 1 patient-derived cell line (CAT12) (Fig.1B-D).

The KE-39 cell line was first evaluated. BRAF, CRAF (RAF1), and SHOC2 were among the top depleted genes (denoting sensitization to SHP2i), and NF1 and PTEN were among the top enriched hits (denoting resistance). The composite group of KRAS-amp models was then evaluated from the secondary screen. Again, NF1 was the top enriched gene when silenced. On average, the top 10 depleted genes were SHOC2, RIC1, GAREM1, CRKL, RAPGEF1, RUNX1, BRAF, TCF7L2, CHD2, and VPS16 in the KRAS-amp cells. These included genes related to the MAPK pathway but also others, including RIC1, GAREM1, CRKL, RUNX1, TCF7L2, CHD2, and VPS16.

(A) Experimental scheme of secondary screening with a focused custom library. (B-D) Volcano plots of KRAS-amp cell lines and a KRAS-mut cell line, GSU, showing different RTK and MAPK genes conferring resistance and sensitivity to SHP099. (B-D) KE-39 (B), CAT12 (C), and YCC1 (D), which have KRAS amplification.Fig. 1 Both genes upstream and downstream of KRAS are potential targets to enhance SHP2i efficacy. (Li T, et al., 2023)

Correlations Between Ploidy Defects and DDR Pathway Activity in Gastric Cancer Cell Lines

Five gastric cancer cell lines (AGS, HGC27, HUGC3, GSU, and KE39) that showed varying levels of aneuploidy (Fig. 2A) and one non-neoplastic diploid cell line (RPE1) were evaluated. Levels of pH2AX and pKAP1 were determined in these cell lines to assess intrinsic DNA DSBs/replication stress. In response to DNA damage and replication stress, KAP1 is phosphorylated at serine 473. As expected, RPE1 cells showed minimal staining for pH2AX and pKAP1. Similarly, low levels of pH2AX and pKAP1 were observed in AGS, a TP53 WT gastric cancer cell line displaying the least aneuploidy defects. In contrast, strong and moderate pH2AX and pKAP1 staining in high (KE39 and GSU) and intermediate (HGC27 and NUGC3) aneuploidy cell lines, respectively (Fig. 2B). Importantly, since dsDNA breaks correlate with DDR response, these markers tracked with one another. As such, pH2AX and pKAP1 levels positively correlated with the degree of various ploidy defect measurements and p53 mutation status (Fig. 2C). GSU and KE39 not only demonstrated greater baseline levels of DNA DSB and replication stress compared to RPE1 and AGS measured by pH2AX and pKAP1 but also showed a more dramatic, dose-dependent induction when treated with prexasertib, a well-known Chk1/2 inhibitor (Fig. 2D-2F).

(A) Ploidy abnormalities scores and p53 status for the five gastric cancer cell lines. (B) Representative immunofluorescence images of pH2AX (red) and pKAP1 (green) stainings in untreated five gastric cancer cell lines and RPE1 cells (non-neoplastic cell line). (C) Quantification of pH2AX and pKAP1 in indicated cell lines expressed as mean fluorescence intensity per cell (MFI) ± S.D from the following number of cells-RPE1-718, AGS-2080, HGC27, 1031, NUGC3-2119, GSU-2092, KE39-577. (D) Quantification of pH2AX staining in prexasertib (Chk1/2) dose-dependent induced replication stress in cell lines. (E) Quantification of pKAP1 staining in prexasertib (Chk1/2) dose-dependent induced replication stress in cell lines. (F) Representative immunofluorescence images of pH2AX (red) and pKAP1 (green) stainings in prexasertib (20nM) treated cell lines.Fig. 2 Aneuploidy correlates with DDR pathway activity in gastric cancer. (Scarpa ES, et al., 2020)

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products